Back

Associations of TyG Index and TyG-obesity-related parameters to cardiovascular disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Obesity (1) Obesity ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Associate Professor Leila Bikdelu

Mashhad University of Medical Sciences, Mashhad (Iran (Islamic Republic of))

6 More presentations in this session

Presentation thumbnail
Tirzepatide treatment and achieving weight reduction >5%, SBP reduction >5 mmHg and non-HDL cholesterol reduction >10%: A post hoc analysis from the SURMOUNT-1 3-year trial
Professor N. Sattar (Glasgow, GB)
Abstract Slides
Presentation thumbnail
Comprehending the genetic obesity basis could help in cardiometabolic disease prevention in women
Doctor D. Sa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Prevalence, risk factors, and time-trends in abdominal obesity in 36 countries in the WHO African region from 2003 to 2022: a study of 53 WHO STEPS surveys representing 156 million adults
Doctor K. Agboyibor (Paris, FR)
Abstract Slides
Presentation thumbnail
New pediatric waist-to-height ratio adiposity cutoff predicts adulthood hypertension: analysis of 7243 participants from NHANES 2021-2023
Doctor D. Corsi (New Brunswick, US)
Abstract Slides Video
Presentation thumbnail
How genetic variants and excess of weight influence risk of coronary artery disease
Doctor G. Bettencourt Abreu (Funchal, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Obesity (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
The triglyceride-glucose index might be a better indicator for predicting poor cardiovascular outcomes in chronic coronary syndrome
thumbnail
Congress Presentation
Derivation and validation of the incremental prognostic value of increased triglyceride glucose index
thumbnail
Congress Presentation
Prognostic impact of composite lipid indices in patients with acute coronary syndrome undergoing percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources